Future of Automation: Making A Difference
Future of Automation: Making A Difference
Look at some changing and unchanging models in the automotive market. Typically, a transition period of technology and business models precipitates small entrepreneurial companies to spring up with new ideas, technologies and target markets. Thus, while Detroit’s Big Three and most other car companies focused on their traditional product and manufacturing models, some serious inventors decided that technology had progressed to the point that an electric car was feasible—and the Tesla was born. Toyota and Honda have jumped into the fray. Ford is making noises. GM is wishing. Chrysler is left wondering who will own it and who will be leading it.
Go a new way
Most disappointing to me is GM’s failure to exploit the promise of the Saturn—a new way to build a car, or at least that’s what the company said. Rather than work with manufacturing to adapt new manufacturing methods to get away from build-to-stock rather than build-to-order, it is evaluating shutting down more factories close to the market and importing cars built in China. That is a short-term solution to a long-term problem.
The business model of ethanol manufacturing shook out even faster. Driven more by farm state political realities than by economics, companies rushed to build plants to convert grain corn into vehicle fuel. The problem is, it takes more energy to make the fuel than the value of the fuel. That’s not to mention that using all of the grain for fuel has the effect of driving up the cost of food. Further, we probably can’t grow enough corn to put a significant dent in our appetite for imported oil. And neither does it do much to promote sales of electric cars.
So, when Wes Iversen volunteered to take on the task of reporting on the latest manufacturing strategies in pharma manufacturing, the results were gratifying. Here is an industry under fire for its blockbuster style of marketing and the resulting high price for drugs adapting to a new way of manufacturing using the latest technologies and methods. This should make pharma manufacturers more responsive to the market and get more products out at a less expensive price point. Yes, manufacturing can make a difference.
Subscribe to Automation World's RSS Feeds for Columns & Departments










Comments(0)
Add new comment